News >

FDA Approves Pexidartinib for Tenosynovial Giant Cell Tumor

Gina Columbus @ginacolumbusonc
Published: Friday, Aug 02, 2019

The FDA has approved pexidartinib (Turalio) for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) that is associated with severe morbidity or functional limitations and not responsive to improvement with surgery.1
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication